{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:33:06Z","timestamp":1787311986148,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hebei Natural Science Foundation","award":["H2022206549"],"award-info":[{"award-number":["H2022206549"]}]},{"name":"Hebei Natural Science Foundation","award":["H2022206358"],"award-info":[{"award-number":["H2022206358"]}]},{"name":"Special Foundation for National Science and Technology Basic Research Program of China","award":["N2019FY101200, 2019FY101204"],"award-info":[{"award-number":["N2019FY101200, 2019FY101204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      (\n                      <jats:italic>C. difficile<\/jats:italic>\n                      ) is the major pathogen causing antibiotic-associated diarrhea. There are a variety of symptoms associated with\n                      <jats:italic>C. difficile<\/jats:italic>\n                      infection (CDI) in adults, including self-limiting diarrhea, pseudomembranous colitis, toxic megacolon, septic shock, and even death from the infection. However, the infant\u2019s intestine appears to be completely resistant to the effects of\n                      <jats:italic>C. difficile<\/jats:italic>\n                      toxins A and B with rare development of clinical symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      In this study, we reported a 1-month-old girl with CDI who was born with neonatal hypoglycemia and necrotizing enterocolitis. Her symptom of diarrhea occurred after extensive use of broad-spectrum antibiotics during hospitalization and was accompanied by elevated white blood cell, platelet, and C-reactive protein levels, and repeated routine stool examinations were abnormal. She was recovered by norvancomycin (an analogue of vancomycin) and probiotic treatment. The results of 16\u00a0S rRNA gene sequencing also demonstrated the recovery of intestinal microbiota with the enrichment of\n                      <jats:italic>Firmicutes<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Based on the literature review and this case report, clinicians should also pay attention to diarrhea caused by\n                      <jats:italic>C. difficile<\/jats:italic>\n                      in infants and young children. More strong evidence is needed to explain the true prevalence of CDI in this population and to better understand the\n                      <jats:italic>C. difficile<\/jats:italic>\n                      -associated diarrhea in infants.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13099-023-00552-1","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T11:02:02Z","timestamp":1688036522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clostridioides difficile infection in infants: a case report and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhirong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirou","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixin","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyi","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"552_CR1","doi-asserted-by":"crossref","unstructured":"Mileto S, Das A, Lyras D. Enterotoxic clostridia: Clostridioides difficile infections. MICROBIOL SPECTR. 2019;7.","DOI":"10.1128\/microbiolspec.GPP3-0015-2018"},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1086\/659156","volume":"32","author":"BA Miller","year":"2011","unstructured":"Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant staphylococcus aureus in community hospitals. INFECT CONT HOSP EP. 2011;32:387\u201390.","journal-title":"INFECT CONT HOSP EP"},{"key":"552_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.anaerobe.2015.10.009","volume":"37","author":"C Janoir","year":"2016","unstructured":"Janoir C. Virulence factors of Clostridium difficile and their role during infection. Anaerobe. 2016;37:13\u201324.","journal-title":"Anaerobe"},{"key":"552_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41467-020-20746-4","volume":"12","author":"JR Fletcher","year":"2021","unstructured":"Fletcher JR, Pike CM, Parsons RJ, Rivera AJ, Foley MH, McLaren MR, et al. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota. NAT COMMUN. 2021;12:462.","journal-title":"NAT COMMUN"},{"key":"552_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","volume":"143","author":"AF Peery","year":"2012","unstructured":"Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the united states: 2012 update. Gastroenterology. 2012;143:1179\u20131187e3.","journal-title":"Gastroenterology"},{"key":"552_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.medmal.2017.10.010","volume":"48","author":"SM Heimann","year":"2018","unstructured":"Heimann SM, Cruz AM, Mellinghof S, Vehreschild M. Economic burden and cost-effective management of Clostridium difficile infections. MED MALADIES INFECT. 2018;48:23\u20139.","journal-title":"MED MALADIES INFECT"},{"key":"552_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/MOG.0000000000000018","volume":"30","author":"H Honda","year":"2014","unstructured":"Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. CURR OPIN GASTROEN. 2014;30:54\u201362.","journal-title":"CURR OPIN GASTROEN"},{"key":"552_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). CLIN INFECT DIS. 2018;66:e1\u2013e48.","journal-title":"CLIN INFECT DIS"},{"key":"552_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1017\/ice.2014.39","volume":"36","author":"L Furuya-Kanamori","year":"2015","unstructured":"Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L, Paterson DL, et al. Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis. INFECT CONT HOSP EP. 2015;36:132\u201341.","journal-title":"INFECT CONT HOSP EP"},{"key":"552_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-micro-091014-104115","volume":"69","author":"CM Theriot","year":"2015","unstructured":"Theriot CM, Young VB. Interactions between the gastrointestinal microbiome and Clostridium difficile. ANNU REV MICROBIOL. 2015;69:445\u201361.","journal-title":"ANNU REV MICROBIOL"},{"key":"552_CR11","doi-asserted-by":"publisher","first-page":"e0182307","DOI":"10.1371\/journal.pone.0182307","volume":"12","author":"N Stoesser","year":"2017","unstructured":"Stoesser N, Eyre DW, Quan TP, Godwin H, Pill G, Mbuvi E, et al. Epidemiology of Clostridium difficile in infants in oxfordshire, uk: risk factors for colonization and carriage, and genetic overlap with regional c. difficile infection strains. PLoS ONE. 2017;12:e0182307.","journal-title":"PLoS ONE"},{"key":"552_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijid.2019.01.024","volume":"81","author":"K Plants-Paris","year":"2019","unstructured":"Plants-Paris K, Bishoff D, Oyaro MO, Mwinyi B, Chappell C, Kituyi A, et al. Prevalence of Clostridium difficile infections among kenyan children with diarrhea. INT J INFECT DIS. 2019;81:66\u201372.","journal-title":"INT J INFECT DIS"},{"key":"552_CR13","unstructured":"Wang WP et al. Pediatrics: People\u2019s Medical Press; 2018."},{"key":"552_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. Dada2: high-resolution sample inference from illumina amplicon data. NAT METHODS. 2016;13:581\u20133.","journal-title":"NAT METHODS"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1111\/mec.12481","volume":"22","author":"U Koljalg","year":"2013","unstructured":"Koljalg U, Nilsson RH, Abarenkov K, Tedersoo L, Taylor AF, Bahram M, et al. Towards a unified paradigm for sequence-based identification of fungi. MOL ECOL. 2013;22:5271\u20137.","journal-title":"MOL ECOL"},{"key":"552_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13059-021-02463-3","volume":"22","author":"L Xiao","year":"2021","unstructured":"Xiao L, Wang J, Zheng J, Li X, Zhao F. Deterministic transition of enterotypes shapes the infant gut microbiome at an early age. GENOME BIOL. 2021;22:243.","journal-title":"GENOME BIOL"},{"key":"552_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/femsre\/fux048","volume":"41","author":"R Chandrasekaran","year":"2017","unstructured":"Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS MICROBIOL REV. 2017;41:723\u201350.","journal-title":"FEMS MICROBIOL REV"},{"key":"552_CR18","first-page":"G178","volume":"280","author":"C Pothoulakis","year":"2001","unstructured":"Pothoulakis C, Lamont JT. Microbes and microbial toxins: paradigms for microbial-mucosal interactions ii. The integrated response of the intestine to Clostridium difficile toxins. AM J PHYSIOL-GASTR L. 2001;280:G178\u201383.","journal-title":"AM J PHYSIOL-GASTR L"},{"key":"552_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/00365548.1981.11690365","volume":"13","author":"E Holst","year":"1981","unstructured":"Holst E, Helin I, Mardh PA. Recovery of Clostridium difficile from children. Scand J Infect Dis. 1981;13:41\u20135.","journal-title":"Scand J Infect Dis"},{"key":"552_CR20","first-page":"43","volume":"8","author":"S Matsuki","year":"2005","unstructured":"Matsuki S, Ozaki E, Shozu M, Inoue M, Shimizu S, Yamaguchi N, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of kanazawa, japan. INT MICROBIOL. 2005;8:43\u20138.","journal-title":"INT MICROBIOL"},{"key":"552_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MPG.0b013e3181d29767","volume":"51","author":"S Jangi","year":"2010","unstructured":"Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J PEDIATR GASTR NUTR. 2010;51:2\u20137.","journal-title":"J PEDIATR GASTR NUTR"},{"key":"552_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/cid\/ciz582","volume":"70","author":"LK Kociolek","year":"2020","unstructured":"Kociolek LK, Espinosa RO, Gerding DN, Hauser AR, Ozer EA, Budz M, et al. Natural clostridioides difficile toxin immunization in colonized infants. CLIN INFECT DIS. 2020;70:2095\u2013102.","journal-title":"CLIN INFECT DIS"},{"key":"552_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1172\/JCI115957","volume":"90","author":"R Eglow","year":"1992","unstructured":"Eglow R, Pothoulakis C, Itzkowitz S, Israel EJ, O\u2019Keane CJ, Gong D, et al. Diminished Clostridium difficile toxin a sensitivity in newborn rabbit ileum is associated with decreased toxin a receptor. J CLIN INVEST. 1992;90:822\u20139.","journal-title":"J CLIN INVEST"},{"key":"552_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1542\/peds.2008-0469","volume":"122","author":"J Kim","year":"2008","unstructured":"Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficileassociated disease among inpatients at children\u2019s hospitals in the united states, 2001\u20132006. Pediatrics. 2008;122:1266\u201370.","journal-title":"Pediatrics"},{"key":"552_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jhin.2022.09.004","volume":"130","author":"N Dong","year":"2022","unstructured":"Dong N, Li ZR, Qin P, Qiang CX, Yang J, Niu YN, et al. Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis. J HOSP INFECT. 2022;130:112\u201321.","journal-title":"J HOSP INFECT"},{"key":"552_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J ANTIMICROB CHEMOTH. 2014;69:881\u201391.","journal-title":"J ANTIMICROB CHEMOTH"},{"key":"552_CR27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2147\/TCRM.S229540","volume":"15","author":"A Khalil","year":"2019","unstructured":"Khalil A, Hendaus MA, Elmagboul E, Mohamed A, Deshmukh A, Elmasoudi A. Incidence of Clostridium difficile infection and associated risk factors among hospitalized children in qatar. THER CLIN RISK MANAG. 2019;15:1343\u201350.","journal-title":"THER CLIN RISK MANAG"},{"key":"552_CR28","first-page":"232","volume":"17","author":"JY Na","year":"2014","unstructured":"Na JY, Park JM, Lee KS, Kang JO, Oh SH, Kim YJ. Clinical characteristics of symptomatic Clostridium difficile infection in children: conditions as infection risks and whether probiotics is effective. PEDIATR GASTROENTERO. 2014;17:232\u20138.","journal-title":"PEDIATR GASTROENTERO"},{"key":"552_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2334-11-194","volume":"11","author":"JL Kuntz","year":"2011","unstructured":"Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC INFECT DIS. 2011;11:194.","journal-title":"BMC INFECT DIS"},{"key":"552_CR30","first-page":"1591753","volume":"2016","author":"M Cappella","year":"2016","unstructured":"Cappella M, Pugliese F, Zucchini A, Marchetti F. Clostridium difficile enterocolitis and reactive arthritis: a case report and review of the literature. CASE REP PEDIAT. 2016;2016:1591753.","journal-title":"CASE REP PEDIAT"},{"key":"552_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/INF.0b013e31819bdaa3","volume":"28","author":"CL Durand","year":"2009","unstructured":"Durand CL, Miller PF. Severe Clostridium difficile colitis and reactive arthritis in a ten-year-old child. PEDIATR INFECT DIS J. 2009;28:750\u20131.","journal-title":"PEDIATR INFECT DIS J"},{"key":"552_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fped.2020.00254","volume":"8","author":"Y Liang","year":"2020","unstructured":"Liang Y, He X, Wang T, Chen Y, Huang H, Tang W, et al. Massive hydrothorax and ascites as the primary manifestation of infection with Clostridium difficile: a case report and literature review. FRONT PEDIATR. 2020;8:254.","journal-title":"FRONT PEDIATR"},{"key":"552_CR33","doi-asserted-by":"crossref","first-page":"2050313X1878174","DOI":"10.1177\/2050313X18781742","volume":"6","author":"GM Rojas","year":"2018","unstructured":"Rojas GM, Jarasvaraparn C, Batten L, Custodio H, Gremse DA. Clostridium difficile colitis complicating kawasaki disease in children: two case reports. SAGE OPEN MED CASE R. 2018;6:2050313X18781742.","journal-title":"SAGE OPEN MED CASE R"},{"key":"552_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/adc.63.5.543","volume":"63","author":"EH Price","year":"1988","unstructured":"Price EH, Wright VM, Walker-Smith JA, Tabaqchali S. Clostridium difficile and acute enterocolitis. ARCH DIS CHILD. 1988;63:543\u20135.","journal-title":"ARCH DIS CHILD"},{"key":"552_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1297-319X(03)00056-3","volume":"71","author":"HA Loffler","year":"2004","unstructured":"Loffler HA, Pron B, Mouy R, Wulffraat NM, Prieur AM. Clostridium difficile-associated reactive arthritis in two children. JOINT BONE SPINE. 2004;71:60\u20132.","journal-title":"JOINT BONE SPINE"},{"key":"552_CR36","doi-asserted-by":"publisher","first-page":"000268","DOI":"10.1099\/acmi.0.000268","volume":"3","author":"H Nogueira","year":"2021","unstructured":"Nogueira H, Costa CL, Martins CS, Morais M, Quesada-Gomez C, Carvalho C, et al. Infection with Clostridioides difficile ribotype 046 in a paediatric liver transplant patient. Access Microbiol. 2021;3:000268.","journal-title":"Access Microbiol"},{"key":"552_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.anaerobe.2012.10.002","volume":"18","author":"C Quesada-Gomez","year":"2012","unstructured":"Quesada-Gomez C, Vargas P, Lopez-Urena D, Gamboa-Coronado MM, Rodriguez-Cavallini E. Community-acquired Clostridium difficile nap1\/027-associated diarrhea in an eighteen month old child. Anaerobe. 2012;18:581\u20133.","journal-title":"Anaerobe"},{"key":"552_CR38","first-page":"652","volume":"33","author":"Hong-bin Yang","year":"2018","unstructured":"Yang Hong-bin, Ying FANG. Ren Xiao-xia, HAN Ya-nan. Clostridium difficile enteritis in children: a case report. Chin J Practical Pediatr. 2018;33:652\u20133.","journal-title":"Chin J Practical Pediatr"},{"key":"552_CR39","first-page":"77","volume":"12","author":"HE Guan Jun","year":"2017","unstructured":"Guan Jun HE, Lei-yan WANG, Yu-huan WANG, Chuan-qing HUANG, Ying YU, Hui. Pseudomembranous enteritis caused by Clostridium difficile infection in a child: a case report. Chin J Evid Based Pediatr | Chin J Evid Based Pediatr. 2017;12:77\u20139.","journal-title":"Chin J Evid Based Pediatr | Chin J Evid Based Pediatr"},{"key":"552_CR40","first-page":"1045","volume":"41","author":"A Kader","year":"2004","unstructured":"Kader A, O\u2019Hare B, Valappil MK. Non-antibiotic associated c. Difficile diarrhea in a 7 week-old infant. INDIAN PEDIATR. 2004;41:1045\u20138.","journal-title":"INDIAN PEDIATR"},{"key":"552_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.surg.2017.01.018","volume":"162","author":"LM Napolitano","year":"2017","unstructured":"Napolitano LM, Edmiston CJ. Clostridium difficile disease: diagnosis, pathogenesis, and treatment update. SURGERY. 2017;162:325\u201348.","journal-title":"SURGERY"},{"key":"552_CR42","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1128\/JCM.03014-15","volume":"54","author":"S Antonara","year":"2016","unstructured":"Antonara S, Leber AL. Diagnosis of Clostridium difficile infections in children. J CLIN MICROBIOL. 2016;54:1425\u201333.","journal-title":"J CLIN MICROBIOL"},{"key":"552_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1128\/JCM.01983-10","volume":"49","author":"RA Luna","year":"2011","unstructured":"Luna RA, Boyanton BJ, Mehta S, Courtney EM, Webb CR, Revell PA, et al. Rapid stool-based diagnosis of Clostridium difficile infection by real-time pcr in a children\u2019s hospital. J CLIN MICROBIOL. 2011;49:851\u20137.","journal-title":"J CLIN MICROBIOL"},{"key":"552_CR44","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","volume":"175","author":"CR Polage","year":"2015","unstructured":"Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA INTERN MED. 2015;175:1792\u2013801.","journal-title":"JAMA INTERN MED"},{"key":"552_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MPG.0000000000002944","volume":"72","author":"JM Parnell","year":"2021","unstructured":"Parnell JM, Fazili I, Bloch SC, Lacy DB, Garcia-Lopez VA, Bernard R, et al. Two-step testing for Clostridioides difficile is inadequate in differentiating infection from colonization in children. J PEDIATR GASTR NUTR. 2021;72:378\u201383.","journal-title":"J PEDIATR GASTR NUTR"},{"issue":"Suppl 4","key":"552_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmi.2016.03.010","volume":"22","author":"MJ Crobach","year":"2016","unstructured":"Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, et al. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. CLIN MICROBIOL INFEC. 2016;22(Suppl 4):63\u201381.","journal-title":"CLIN MICROBIOL INFEC"},{"key":"552_CR47","first-page":"80","volume":"17","author":"JO Shim","year":"2014","unstructured":"Shim JO. Clostridium difficile in children: to treat or not to treat? PEDIATR GASTROENTERO. 2014;17:80\u20134.","journal-title":"PEDIATR GASTROENTERO"},{"key":"552_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. NEW ENGL J MED. 2011;364:422\u201331.","journal-title":"NEW ENGL J MED"},{"key":"552_CR49","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. CLIN INFECT DIS. 2011;53:994\u20131002.","journal-title":"CLIN INFECT DIS"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jhin.2018.04.017","volume":"99","author":"LV McFarland","year":"2018","unstructured":"McFarland LV, Ship N, Auclair J, Millette M. Primary prevention of Clostridium difficile infections with a specific probiotic combining lactobacillus acidophilus, l. Casei, and l. Rhamnosus strains: assessing the evidence. J HOSP INFECT. 2018;99:443\u201352.","journal-title":"J HOSP INFECT"},{"key":"552_CR51","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","volume":"101","author":"LV McFarland","year":"2006","unstructured":"McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. AM J GASTROENTEROL. 2006;101:812\u201322.","journal-title":"AM J GASTROENTEROL"},{"key":"552_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3920\/BM2012.0049","volume":"4","author":"M Hell","year":"2013","unstructured":"Hell M, Bernhofer C, Stalzer P, Kern JM, Claassen E. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. BENEF MICROBES. 2013;4:39\u201351.","journal-title":"BENEF MICROBES"},{"key":"552_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jpids\/piab063","volume":"10","author":"AK Semon","year":"2021","unstructured":"Semon AK, Keenan O, Zackular JP. Clostridioides difficile and the microbiota early in life. J PEDIAT INF DIS SOC. 2021;10:3\u2013S7.","journal-title":"J PEDIAT INF DIS SOC"},{"key":"552_CR54","doi-asserted-by":"crossref","unstructured":"Ahearn-Ford S, Berrington JE, Stewart CJ. Development of the gut microbiome in early life. EXP PHYSIOL; 2022.","DOI":"10.1113\/EP089919"},{"key":"552_CR55","doi-asserted-by":"publisher","first-page":"300060520957804","DOI":"10.1177\/0300060520957804","volume":"48","author":"M Duan","year":"2020","unstructured":"Duan M, Han Z, Huang N. Changes of intestinal microflora in neonatal necrotizing enterocolitis: a single-center study. J INT MED RES. 2020;48:300060520957804.","journal-title":"J INT MED RES"},{"key":"552_CR56","doi-asserted-by":"crossref","unstructured":"Schonherr-Hellec S, Klein GL, Delannoy J, Ferraris L, Roze JC, Butel MJ et al. Clostridial strain-specific characteristics associated with necrotizing enterocolitis. APPL ENVIRON MICROB. 2018;84.","DOI":"10.1128\/AEM.02428-17"},{"key":"552_CR57","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3945\/ajcn.117.152967","volume":"106","author":"JC Roze","year":"2017","unstructured":"Roze JC, Ancel PY, Lepage P, Martin-Marchand L, Al NZ, Delannoy J, et al. Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants. AM J CLIN NUTR. 2017;106:821\u201330.","journal-title":"AM J CLIN NUTR"},{"key":"552_CR58","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1038\/s41467-019-13014-7","volume":"10","author":"M Reyman","year":"2019","unstructured":"Reyman M, van Houten MA, van Baarle D, Bosch A, Man WH, Chu M, et al. Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. NAT COMMUN. 2019;10:4997.","journal-title":"NAT COMMUN"},{"key":"552_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1560-1","volume":"574","author":"Y Shao","year":"2019","unstructured":"Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574:117\u201321.","journal-title":"Nature"},{"key":"552_CR60","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.chom.2015.04.004","volume":"17","author":"F Backhed","year":"2015","unstructured":"Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. CELL HOST MICROBE. 2015;17:690\u2013703.","journal-title":"CELL HOST MICROBE"},{"key":"552_CR61","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/1471-0528.16633","volume":"128","author":"NT Mueller","year":"2021","unstructured":"Mueller NT, Differding MK, Ostbye T, Hoyo C, Benjamin-Neelon SE. Association of birth mode of delivery with infant faecal microbiota, potential pathobionts, and short chain fatty acids: a longitudinal study over the first year of life. BJOG-INT J OBSTET GY. 2021;128:1293\u2013303.","journal-title":"BJOG-INT J OBSTET GY"},{"key":"552_CR62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/INF.0000000000002559","volume":"39","author":"EA Lees","year":"2020","unstructured":"Lees EA, Carrol ED, Ellaby N, Roberts P, Corless CE, Lenzi L, et al. Characterization of circulating Clostridium difficile strains, host response and intestinal microbiome in hospitalized children with diarrhea. PEDIATR INFECT DIS J. 2020;39:221\u20138.","journal-title":"PEDIATR INFECT DIS J"},{"key":"552_CR63","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/cid\/ciab414","volume":"73","author":"PJ Maziade","year":"2021","unstructured":"Maziade PJ, Ship N, Sniffen JC, Goldstein E. Enhanced Clostridioides difficile infection prevention with a pharmacy-controlled policy that adds a 3-strain lactobacillus probiotic concomitantly to antibiotic therapy. CLIN INFECT DIS. 2021;73:1524\u20137.","journal-title":"CLIN INFECT DIS"},{"key":"552_CR64","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/INF.0000000000002480","volume":"38","author":"L Malmqvist","year":"2019","unstructured":"Malmqvist L, Ullberg M, Hed MI, Nilsson A. Clostridium difficile infection in children: epidemiology and trend in a swedish tertiary care hospital. PEDIATR INFECT DIS J. 2019;38:1208\u201313.","journal-title":"PEDIATR INFECT DIS J"},{"key":"552_CR65","unstructured":"Laursen MF. Gut microbiota development: influence of diet from infancy to toddlerhood. ANN NUTR METAB. 20211\u201314."}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-023-00552-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:03:13Z","timestamp":1688040193000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-023-00552-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1186\/s13099-023-00552-1","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by The Second Hospital of Hebei Medical University (Approval No. 2021-R521). The participants or legal guardians gave written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"Written informed consent for publication of case details and any accompanying images was obtained from the patient\u2019s parents described in this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"31"}}